Shane Schaffer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA New Drug Application In The Works For This Innovator In ADHD Drug Delivery

FDA New Drug Application In The Works For This Innovator In ADHD Drug Delivery
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Peterj werthShane schafferBoard memberPrecision timed release

Cingulate CFO Louis G Van Horn Retiring >CING

By Dean Seal The chief financial officer of Cingulate retired this week amid an exodus of officers and board members. The clinical stage biopharmaceutical.

Scott applebaumLouis van hornShane schafferCraig gilgallonLaurie myerCurt medeirosPatrick gallagherDrug administrationExecutive shane schafferGregg givensChief operating officer laurie myerNew drug applicationDean sealArticle normalManagement movesCorporate industrial news

Cingulate Shares Hit Record Low After Exodus of Officers, Directors

By Dean Seal Shares of Cingulate tumbled to an all-time low after the company disclosed that several officers and directors have departed amid major.

Shane schafferCurt medeirosScott applebaumCraig gilgallonLouis van hornLaurie myerPatrick gallagherDrug administrationGregg givensChief executive shane schafferChief operating officer laurie myerNew drug applicationDean sealArticle normalCorporate industrial newsIndustrial news

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now

Presenting on the Emerging Growth Conference 65 Day 1 on December 6th Register Now
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesRaouf youssef halimFieldpoint equitykeynoteNeala luxDennis calvertAnatoly dritschiloBryan lewisHans bredrupAneel singhPaul elliot mannCarolyn jane myersDavid mehalickJeremy jiOwent carhartDavid doddVasilis besikiotis

Cingulate and Indegene announce agreement for lead ADHD drug

An agreement has been reached to promote Cingulate Inc’s ‘first true entire active day medication’ designed to treat attention deficit hyperactivity disorder (ADHD).

Timothy mooreShane schafferDrink administrationDrug deliveryClinical developmentMarkets amp regulationsAtient centricityPis active pharmaceutical ingredientsDelivery formulationsDelivery technologiesPhase iii ivDrug deliveryDrug delivery systemsClinical trial